Treatment of murine osteoarthritis with TrkAd5 reveals a pivotal role for nerve growth factor in non-inflammatory joint pain
Authors:
- Annika BurleighABAnnika Burleigh
- Luke L. GompelsLGLuke L. Gompels
- Marc FeldmannMFMarc Feldmann
- Shelley J. AllenSAShelley J. Allen
- Richard O. WilliamsRWRichard O. Williams
- David DawbarnDDDavid Dawbarn
- Tonia L. VincentTVTonia L. Vincent
- Julia J. InglisJIJulia J. Inglis
- 1 May 2010
- journal article
- Published by Wolters Kluwer Health in Pain
- Vol. 149 (2) , 386-392
Abstract
The origin of pain in osteoarthritis is poorly understood, but it is generally thought to arise from inflammation within the innervated structures of the joint, such as the synovium, capsule and bone. We investigated the role of nerve growth factor (NGF) in pain development in murine OA, and the analgesic efficacy of the soluble NGF receptor, TrkAD5. OA was induced in mice by destabilisation of the medial meniscus and pain was assessed by measuring hind-limb weight distribution. RNA was extracted from joints, and NGF and TNF expressions were quantified. The effect of tumour necrosis factor (TNF) and neutrophil blockade on NGF expression and pain were also assessed. NGF was induced in the joints during both post-operative (day 3) and OA (16weeks) pain, but not in the non-painful stage of disease (8weeks post-surgery). TrkAd5 was highly effective at suppressing pain in both phases. Induction of NGF in the post-operative phase of pain was TNF-dependent as anti-TNF reduced NGF expression in the joint and abrogated pain. However, TNF was not regulated in the late OA joints, and pain was not affected by anti-TNF therapy. Fucoidan, by suppressing cellular infiltration into the joint, was able to suppress post-operative, but not late OA pain. These results indicate that NGF is an important mediator of OA pain and that TrkAd5 represents a potent novel analgesic in this condition. They also suggest that, unlike post-operative pain, induction of pain in OA may not necessarily be driven by classical inflammatory processes.Keywords
Funding Information
- Arthritis Research Campaign
This publication has 36 references indexed in Scilit:
- Low affinity NGF receptor (p75 neurotrophin receptor) inhibitory antibody reduces pain behavior and CGRP expression in DRG in the mouse sciatic nerve crush modelJournal of Orthopaedic Research, 2009
- Local and Systemic Release of Cytokines, Nerve Growth Factor, Prostaglandin E2, and Substance P in Incisional Wounds and Serum Following Cesarean DeliveryThe Journal of Pain, 2008
- Crucial role of neutrophils in the development of mechanical inflammatory hypernociceptionJournal of Leukocyte Biology, 2008
- TNF-α and IL-1β mediate inflammatory hypernociception in mice triggered by B1 but not B2 kinin receptorEuropean Journal of Pharmacology, 2007
- Characterisation of ultraviolet-B-induced inflammation as a model of hyperalgesia in the ratPain, 2007
- A comparative study of the anti-inflammatory, anticoagulant, antiangiogenic, and antiadhesive activities of nine different fucoidans from brown seaweedsGlycobiology, 2007
- Primer: managing NSAID-induced ulcer complications—balancing gastrointestinal and cardiovascular risksNature Clinical Practice Gastroenterology & Hepatology, 2006
- Attenuation of experimental arthritis in TRPV1R knockout miceExperimental and Molecular Pathology, 2006
- Cellular pathology changes in rat skin following intradermal injection of nerve growth factor: neutrophil‐dependent and ‐independent eventsThe Journal of Pathology, 2002
- Nerve growth factor induced hyperalgesia in the rat hind paw is dependent on circulating neutrophilsPain, 1998